Clinical Trial Update: Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting bone mineral density results in patients with chronic obstructive pulmonary disease treated with the DISKUS inhaler; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Diskus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2018-03-20